63 related articles for article (PubMed ID: 2633005)
21. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
La Quaglia MP; Black T; Holcomb GW; Sklar C; Azizkhan RG; Haase GM; Newman KD
J Pediatr Surg; 2000 Jun; 35(6):955-9; discussion 960. PubMed ID: 10873043
[TBL] [Abstract][Full Text] [Related]
22. Long-term survival in sporadic and familial medullary thyroid carcinoma with special reference to clinical characteristics as prognostic factors. The Swedish MTC Study Group.
Bergholm U; Adami HO; Bergström R; Bäckdahl M; Akerström G
Acta Chir Scand; 1990 Jan; 156(1):37-46. PubMed ID: 2321439
[TBL] [Abstract][Full Text] [Related]
23. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
24. Medullary thyroid carcinoma experienced at Kanazawa University Hospital.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ohtake S; Nakamura S; Ishizaki T
J Surg Oncol; 1996 Jan; 61(1):27-33. PubMed ID: 8544456
[TBL] [Abstract][Full Text] [Related]
25. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis.
Hughes CJ; Shaha AR; Shah JP; Loree TR
Head Neck; 1996; 18(2):127-32. PubMed ID: 8647677
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic and flow cytometric DNA study of medullary thyroid carcinoma.
el-Naggar AK; Ordonez NG; McLemore D; Schultz P; Hickey RC; Samaan N
Surgery; 1990 Dec; 108(6):981-5. PubMed ID: 2247844
[TBL] [Abstract][Full Text] [Related]
27. Papillary thyroid carcinoma: factors influencing recurrence and survival.
Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
[TBL] [Abstract][Full Text] [Related]
28. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
Liu WS; Qi YF; Tang PZ
Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
[TBL] [Abstract][Full Text] [Related]
29. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients.
Scopsi L; Sampietro G; Boracchi P; Del Bo R; Gullo M; Placucci M; Pilotti S
Cancer; 1996 Nov; 78(10):2173-83. PubMed ID: 8918412
[TBL] [Abstract][Full Text] [Related]
30. Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma.
Marchesi M; Biffoni M; Biancari F; Berni A; Campana FP
Eur J Surg Suppl; 2003 Jul; (588):46-50. PubMed ID: 15200043
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of surgical treatment results in patients with differentiated thyroid cancer from materials in the Oncologic Institute in Gliwice].
Włoch J; Czarniecka A; Turska M; Wilgus J
Wiad Lek; 2001; 54 Suppl 1():178-88. PubMed ID: 12182023
[TBL] [Abstract][Full Text] [Related]
32. Clinical and histological differences in anaplastic thyroid carcinoma.
Rodriguez JM; Piñero A; Ortiz S; Moreno A; Sola J; Soria T; Robles R; Parrilla P
Eur J Surg; 2000 Jan; 166(1):34-8. PubMed ID: 10688214
[TBL] [Abstract][Full Text] [Related]
33. Neck management in medullary thyroid carcinoma.
Oskam IM; Hoebers F; Balm AJ; van Coevorden F; Bais EM; Hart AM; van den Brekel MW
Eur J Surg Oncol; 2008 Jan; 34(1):71-6. PubMed ID: 17555910
[TBL] [Abstract][Full Text] [Related]
34. Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma.
Fontanini G; Vignati S; Pacini F; Pollina L; Basolo F
Mod Pathol; 1996 Jun; 9(6):636-41. PubMed ID: 8782200
[TBL] [Abstract][Full Text] [Related]
35. Central neck dissection in the management of sporadic medullary thyroid microcarcinoma.
Hamy A; Pessaux P; Mirallié E; Mucci-Hennekinne S; Gibelin H; Mor-Martinez C; de Calan L; Ronceray J; Kraimps JL
Eur J Surg Oncol; 2005 Sep; 31(7):774-7. PubMed ID: 15925476
[TBL] [Abstract][Full Text] [Related]
36. Importance of lymph node metastases in follicular thyroid cancer.
Witte J; Goretzki PE; Dieken J; Simon D; Röher HD
World J Surg; 2002 Aug; 26(8):1017-22. PubMed ID: 12045860
[TBL] [Abstract][Full Text] [Related]
37. [Type of surgery for 147 patients with medullary carcinoma of the thyroid].
Huang CP; Zhu YX; Tian AL
Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):490-2. PubMed ID: 14575577
[TBL] [Abstract][Full Text] [Related]
38. [Medullary thyroid carcinoma: prognostic factors].
Pelizzo MR; Busnardo B; Bernante P; Girelli ME; Nacamulli D; Toniato A; Piotto A
Minerva Chir; 1993 Nov; 48(21-22):1289-91. PubMed ID: 8152559
[TBL] [Abstract][Full Text] [Related]
39. Childhood and adolescent thyroid carcinoma.
Grigsby PW; Gal-or A; Michalski JM; Doherty GM
Cancer; 2002 Aug; 95(4):724-9. PubMed ID: 12209714
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in follicular carcinoma of the thyroid: a study of 198 cases.
Rao RS; Parikh HK; Deshmane VH; Parikh DM; Shrikhande SS; Havaldar R
Head Neck; 1996; 18(2):118-24; discussion 124-6. PubMed ID: 8647676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]